Yield Growth Hits the Accelerator after Revenues Jump in Q3
November 6th, 2019
App, Exclusive, News, Top News
The global winds for legalization of marijuana continue to gain speed despite a policy paradox within many countries. In North America, Canada made recreational cannabis legal a year ago and expanded product forms last month. 33 U.S. states now allow medical and/or recreational marijuana, despite the plant remaining illegal at the federal level. Overseas, the European Parliament earlier this year voted for advancing medical marijuana. With the resolution, Parliament joined the World Health Organization in recommending rescheduling cannabis under international drug agreements, while incentivizing countries to expand access to the plant and its medically beneficial compounds.
That’s a nice backdrop for The Yield Growth Corp (CSE: BOSS)(OTCQB: BOSQF) to build its international footprint, and it shows in the company’s third quarter results and developments to ring in the fourth quarter.
Urban Juve Leads Revenues Upwards
Yield Growth has seven subsidiaries, including the newly-minted edible mushroom brand Flourish Mushroom Labs, which gives the company diverse revenue streams and exposure to cannabis, hemp and edible mushroom segments within the $4.2 trillion global wellness market.
The flagship brand is Urban Juve, a hemp-based, Ayurveda-inspired skincare line sold internationally via the company’s e-commerce site and North American brick and mortar points of sale. Additionally, a broad and growing distribution network of potential new retail locations has been established throughout the U.S., Canada and Europe. North American brick and mortar distribution began this year through a sales partnership. This subsidiary is already in revenues with licensing and sales revenues received and 14 product SKUs now for sale.
The sales efforts are paying off. After logging revenues of around $200,000 in Q2 2018, quarterly revenue has taken an uphill trajectory, topping $1.0 million for the first time during the second quarter of this year.
The third quarter was even stronger, with revenue improving 61% quarter-over-quarter to $1.9 million. That was an increase of 355% from about $400,000 in Q3, 2018.
Furthermore, Yield Growth maintained its practice of growing value without taking on convertible debt, an anomaly amongst cannabis/hemp-focused companies. In fact, BOSS has zero short-term loans, no long-term loans and no commercial debt. All the while, growing total assets to $6.5 million at the end of Q3 from $2.6 million at the end of 2018.
Strong Quarter, Bright Future
Americans want legal marijuana, as evidenced by a recent Gallop poll showing two out of every three people favor legal cannabis. As mentioned, more products are coming to the Canadian markets with new laws dubbed Cannabis 2.0. European authorities are supportive of legal cannabis. Yield Growth is well positioned to capitalize on the worldwide trend with its hemp-derived Urban Juve products that fall under the parameters of international treaties and the 2018 U.S. Farm Bill that legalized hemp sales nationwide, as well as with the Wright & Well™ brand in Oregon.
Recreational marijuana has been legal in Oregon since 2014. The company recently attained Oregon Liquor Control Commission final approval for 9 Wright & Well products, allowing the new products to be sold through cannabis retailers across the state.
On the heels of obtaining Compliance Certificates for the sale of Urban Juve products in Europe, Yield Growth forged a new partnership with performance marketing company Green Space Worldwide. Per the accord, Green Space, who prides itself on only taking on a limited number of premium-brand clients, will market Urban Juve’s product bundles across all facets of digital media, leveraging their internal media buying teams and rolodex of celebrity influencers.
Elsewhere, Yield Growth entered license and distribution agreements expanding its reach in the U.S., Canada, Greece, Cyprus, Brazil and Colombia. The brand awareness strategy has been ratcheted up through Urban Juve products being featured in British Vogue, Vanity Fair UK and Elle Canada, as well as hugely popular websites like Leafly and Shopper, an e-commerce asset of beauty giant IPSY.
Yield Growth is forecasting $250,000 in new order deliveries ($150,000 in U.S., $100,00 in Greece) for next quarter..
Moreover, THC and CBD products under the Jack N Jane moniker are getting ready to be launched throughout Canada as detailed in a potential co-packing agreement with LP Apothecary Botanicals, a subsidiary of Geyser Brands Inc. (TSX-V: GYSR).
With the cannabis/hemp initiatives hitting their stride, BOSS management is exploring the lucrative edible mushrooms market. And they’re not wasting any time either. Only weeks after announcing the new Flourish Mushroom Labs subsidiary and the acquisition of a library of edible mushroom formulas, the company said it has already completed initial development of a mushroom coffee formula.
The plan is to launch a new line of antioxidant-rich, mushroom-infused coffee mixes early in 2020.
This is one of those market opportunities that is often overlooked for its potential. According to analysts at Research and Markets, the global functional food market is growing 8% annually and will reach $34.3 billion by 2024.
The company is also considering the psychoactive component to so-called “magic mushrooms” that are being analyzed for treating a range of mental health conditions.
Covering all the Bases
THC. CBD. Hemp. Mushrooms. Canada. U.S. Europe. South America. Cumulatively, these words represent markets into the trillions of dollars, many of which are only now emerging. No debt speaks to the skillsets of management as the company moves quickly and with precision to address all of these opportunities at hand.
CannabisFN.com is not an independent financial investment advisor or broker-dealer. You should always consult with your own independent legal, tax, and/or investment professionals before making any investment decisions. The information provided on https://www.cannabisfn.com (the ‘Site’) is either original financial news or paid advertisements drafted by our in-house team or provided by an affiliate. CannabisFN.com, a financial news media and marketing firm enters into media buys or service agreements with the companies that are the subject of the articles posted on the Site or other editorials for advertising such companies. We are not an independent news media provider. We make no warranty or representation about the information including its completeness, accuracy, truthfulness or reliability and we disclaim, expressly and implicitly, all warranties of any kind, including whether the Information is complete, accurate, truthful, or reliable. As such, your use of the information is at your own risk. Nor do we undertake any obligation to update the items posted. CannabisFN.com received compensation for producing and presenting high quality and sophisticated content on CannabisFN.com along with financial and corporate news.
This article was published by CFN Enterprises Inc. (OTCQB: CNFN), owner and operator of CFN Media, the industry’s leading agency and digital financial media network dedicated to the burgeoning CBD and legal cannabis industries. Call +1 (833) 420-CNFN for more information.
Follow Us on Social Media
About CFN Media Group
CFN Enterprises Inc. (OTCQB: CNFN) owns and operates CFN Media Group, the premier agency and financial media network reaching executives, entrepreneurs and consumers worldwide. Through its proprietary content creation, video library, and distribution via www.CannabisFN.com, CFN has built an extensive database of cannabis interest, assisting many of the world’s largest cannabis firms and CBD brands to build awareness and thrive. For more information, please visit www.cfnenterprisesinc.com.
Disclaimer: Matters discussed on this website contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time-to-time have a position in the securities mentioned herein and will increase or decrease such positions without notice. The Information contains forward-looking statements, i.e. statements or discussions that constitute predictions, expectations, beliefs, plans, estimates, or projections as indicated by such words as "expects", "will", "anticipates", and "estimates"; therefore, you should proceed with extreme caution in relying upon such statements and conduct a full investigation of the Information and the Profiled Issuer as well as any such forward-looking statements. Any forward looking statements we make in the Information are limited to the time period in which they are made, and we do not undertake to update forward looking statements that may change at any time; The Information is presented only as a brief "snapshot" of the Profiled Issuer and should only be used, at most, and if at all, as a starting point for you to conduct a thorough investigation of the Profiled Issuer and its securities and to consult your financial, legal or other adviser(s) and avail yourself of the filings and information that may be accessed at www.sec.gov, www.pinksheets.com, www.otcmarkets.com or other electronic sources, including: (a) reviewing SEC periodic reports (Forms 10-Q and 10-K), reports of material events (Form 8-K), insider reports (Forms 3, 4, 5 and Schedule 13D); (b) reviewing Information and Disclosure Statements and unaudited financial reports filed with the Pink Sheets or www.otcmarkets.com; (c) obtaining and reviewing publicly available information contained in commonlyknown search engines such as Google; and (d) consulting investment guides at www.sec.gov and www.finra.com. You should always be cognizant that the Profiled Issuers may not be current in their reporting obligations with the SEC and OTCMarkets and/or have negative signs at www.otcmarkets.com (See section below titled "Risks Related to the Profiled Issuers, which provides additional information pertaining thereto). For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity-based compensation in the companies it writes about, or a combination of the two. For full disclosure, please visit: https://www.cannabisfn.com/legal-disclaimer/. A short time after we acquire the securities of the foregoing company, we may publish the (favorable) information about the issuer referenced above advising others, including you, to purchase; and while doing so, we may sell the securities we acquired. In addition, a third-party shareholder compensating us may sell his or her shares of the issuer while we are publishing favorable information about the issuer. Except for the historical information presented herein, matters discussed in this article contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time to time have a position in the securities mentioned herein and will increase or decrease such positions without notice. For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity- based compensation in the companies it writes about, or a combination of the two. For full disclosure please visit: https://www.cannabisfn.com/legal-disclaimer/.